Results 181 to 190 of about 74,876 (285)

Targeting EZH2 in Cancer: From Molecular Mechanisms to Clinical Translation

open access: yesMedComm – Oncology, Volume 5, Issue 2, June 2026.
The abnormal overexpression or gain‐of‐function mutations of EZH2 play a significant role in cancer occurrence and progression, highlighting the importance and potential of EZH2 as a cancer biomarker. Therefore, screening for effective and safe small‐molecule inhibitors, degraders, and natural compounds targeting EZH2 through preclinical cancer models ...
Xi Zhong   +4 more
wiley   +1 more source

Identification of Papillary Thyroid Carcinoma in Indeterminate Nodules. [PDF]

open access: yesRadiol Imaging Cancer
Dou Y   +5 more
europepmc   +1 more source

On why cancer cells require a great amount of glucose

open access: yesQuantitative Biology, Volume 14, Issue 2, June 2026.
Abstract The traditional thinking has been that cancer cells require a great amount of glucose to support their rapid growth, but the reality may be different. We have previously demonstrated that all cancer cells in The Cancer Genome Atlas harbor persistent Fenton reactions in their cytosol, which generate OH− ${\text{OH}}^{-}$ and ultimately kill the
Xuechen Mu   +6 more
wiley   +1 more source

Changes in the microbiome and metabolome in captive red kangaroos (Osphranter rufus) affected by macropod progressive periodontal disease

open access: yesAustralian Veterinary Journal, Volume 104, Issue 6, Page 365-375, June 2026.
Macropod progressive periodontal disease (MPPD) is a severe oral condition frequently observed in captive macropods, particularly red kangaroos (Osphranter rufus), yet its underlying biological features remain poorly understood. In this exploratory descriptive study, we investigated oral and fecal microbiomes and metabolomic profiles in captive red ...
Y Yoshimoto   +4 more
wiley   +1 more source

Coexistence of medullary and papillary thyroid carcinoma in the same lobe-isthmus complex: A case report. [PDF]

open access: yesBioinformation
Murali G   +5 more
europepmc   +1 more source

Discovery of a Novel γ‐Glutamylcyclotransferase Inhibitor Plumbagin by Luminescence‐Based High‐Throughput Screening

open access: yesCancer Science, Volume 117, Issue 6, Page 1713-1723, June 2026.
A cell‐based high‐throughput screening system utilizing the luminescent probe LISA‐103 was developed to monitor γ‐glutamylcyclotransferase (GGCT) activity in cancer cells. Through this assay, plumbagin was identified as a novel GGCT inhibitor that induces cell cycle arrest and suppresses cancer cell growth. ABSTRACT γ‐Glutamylcyclotransferase (GGCT) is
Keiko Taniguchi   +10 more
wiley   +1 more source

Thyroid cancer treatment

open access: yes
Thyroid cancer is one of the most common endocrine tumors in the community, and it has been on the rise for several decades. The disease is categorized into four subtypes of cancer: papillary, follicular, medullary, and anaplastic thyroid cancer, each of
Saito, Zen
core  

The diagnosis and management of ectopic thyroid cancer: a systematic review. [PDF]

open access: yesFront Endocrinol (Lausanne)
Quan M   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy